3 risultati
FIELD
Disclosed herein are pharmaceutical compositions comprising K.sub.ATP channel modulators and CB.sub.x modulators and the use of said pharmaceutical compositions for the treatment of one or more medical conditions such as, for example, obesity, diabetes mellitus, metabolic syndrome, syndrome X,
The present invention relates to a novel combination therapy for diabetes mellitus type I and/or for obesity and its concomitant and/or secondary diseases or conditions, in particular the metabolic syndrome and/or syndrome X, and/or diabetes mellitus type II, by administering a combination of at
BACKGROUND
Many dietary supplements, food ingredients, and foods are referred to as "nutraceuticals." An item is often referred to as a nutraceutical when it is believed to provide both a "nutritious" and "healthy" effect (i.e., the item has an effect similar to a pharmaceutical) to the person